In general, activation of liver FXR signaling is beneficial for primary biliary cirrhosis and non-alcoholic steatohepatitis (NASH) by reducing bile acid pool and progression to fibrosis16,17. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.